drugset / Trial / NCT02269189
Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
Safety, tolerability and pharmacokinetics following repeated doses (15-day dosing)
Timeline
- Start
- 2002-04
- Primary completion
- 2002-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMELUBANT | Small molecule | 150 mg | Oral |
| Subject | AMELUBANT | Small molecule | 300 mg | Oral |